← Current compounder rows

Current NDC auxiliary source row compounder:4064

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
71285-0212
Product Ndc
71285-0212
Product Ndc Digits
712850212
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Induction 4 to1 High K (30 meq) In PL A
Proprietary Name Suffix
[empty]
Nonproprietary Name
Induction 4 to1 High K (30 meq) In PL A
Dosage Form Name
SOLUTION
Route Name
INTRACORONARY
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Central Admixture Pharmacy Services, Inc.
Establishment Name
Central Admixture Pharmacy Services, Inc.
Establishment Fei
[empty]
Substance Name
SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE
Active Ingredients Info
2.63 g/542 mL; 2.51 g/542 mL; 1.84 g/542 mL; 2.42 g/542 mL; .15 g/542 mL; 100 mg/542 mL; 1.848 g/542 mL
History Active Ingredients Raw
SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE
History Active Ingredients Info Raw
2.63 g/542 mL; 2.51 g/542 mL; 1.84 g/542 mL; 2.42 g/542 mL; .15 g/542 mL; 100 mg/542 mL; 1.848 g/542 mL
History Dosage Raw
SOLUTION
Dea Schedule
[empty]
Package Ndc Raw
71285-0212-1
Package Ndc
71285-0212-1
Package Ndc Digits
7128502121
Package Ndc11
71285021201
Package Description
542 mL in 1 BAG (71285-0212-1)
Reporting Period Raw
2025-2
Reporting Period
2025-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:4064
Source Row Number
4064
Source Row Hash
e6d46992508bd3c29ab45debf834431181d46ff83405fbc51e2cc1914f0e9c32
Import Run Id
20261026T055812Z
Loaded At
2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACORONARY",
    "PRODUCTNDC": "71285-0212",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "71285-0212-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Induction 4 to1 High K (30 meq) In PL A",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Induction 4 to1 High K (30 meq) In PL A",
    "PACKAGEDESCRIPTION": "542 mL in 1 BAG (71285-0212-1) ",
    "ACTIVEINGREDIENTSINFO": "2.63 g/542 mL; 2.51 g/542 mL; 1.84 g/542 mL; 2.42 g/542 mL; .15 g/542 mL; 100 mg/542 mL; 1.848 g/542 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:4064
Source Row Number
4064
Status Scope
package
Lookup Ndc
71285-0212-1
Lookup Ndc Digits
7128502121
Product Ndc
71285-0212
Product Ndc Digits
712850212
Package Ndc
71285-0212-1
Package Ndc Digits
7128502121
Package Ndc11
71285021201
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-2
Reporting Period
2025-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
e6d46992508bd3c29ab45debf834431181d46ff83405fbc51e2cc1914f0e9c32
Import Run Id
20261026T055812Z
Loaded At
2026-10-26 06:02:33